-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on GoodRx Holdings, Lowers Price Target to $4

Benzinga·12/18/2025 17:56:12
Listen to the news
Morgan Stanley analyst Craig Hettenbach maintains GoodRx Holdings (NASDAQ:GDRX) with a Equal-Weight and lowers the price target from $5 to $4.